11.90
Research Alliance Corp Iv stock is traded at $11.90, with a volume of 1,262.
It is up +0.85% in the last 24 hours and up +14.20% over the past month.
See More
Previous Close:
$11.80
Open:
$12
24h Volume:
1,262
Relative Volume:
0.44
Market Cap:
$108.27M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+2.32%
1M Performance:
+14.20%
6M Performance:
+0.00%
1Y Performance:
+0.00%
Research Alliance Corp Iv Stock (RACD) Company Profile
Name
Research Alliance Corp Iv
Sector
Industry
Phone
-
Address
-
Compare RACD vs LION, UMAC, XXI, CCXI, EVAC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
RACD
Research Alliance Corp Iv
|
11.90 | 103.91M | 0 | 0 | 0 | 0.00 |
|
LION
Lionsgate Studios Corp
|
11.99 | 3.49B | 2.63B | -175.60M | 11.40M | -0.7173 |
|
UMAC
Unusual Machines Inc
|
34.06 | 1.35B | 17.25M | -5.64M | -40.16M | -0.3337 |
|
XXI
Twenty One Capital Inc
|
4.78 | 1.63B | 0 | 4.35M | 456.40K | 0.3397 |
|
CCXI
Churchill Capital Corp Xi
|
17.07 | 901.78M | 0 | 0 | 0 | 0.0647 |
|
EVAC
Eqv Ventures Acquisition Corp Ii
|
10.26 | 599.11M | 0 | 12.80M | -714.00K | 0.2184 |
Research Alliance Corp Iv Stock (RACD) Latest News
Research Alliance Corporation IV (RACD) Stock Trends and Sentiment 2026 - MarketBeat
VSCTF Stock Price and Chart — OTC:VSCTF - TradingView
Research Alliance Corporation IV (RACD) Analyst insights, Price targets and Recommendations - Yahoo Finance UK
All News for RACD : Research Alliance Corporation IV - Zacks Investment Research
Should I buy Research Alliance Corporation IV (RACD) - Zacks Investment Research
Upcoming & Recent IPO'sIPOs Calendar - Yahoo Finance
RACD Should I Buy - Intellectia AI
RACD Technical Analysis & Stock Price Forecast - Intellectia AI
RACD | Research Alliance Corporation IV Institutional Ownership - Quiver Quantitative
RACD | Research Alliance Corporation IV Stock Data, Price & News - Quiver Quantitative
OHB Pediatrics Ltd. entered into a definitive business combination agreement to acquire Research Alliance Corporation III from Research Alliance Holdings III LLC and others for approximately $160 million in a reverse merger transaction. - marketscreener.com
Form 4 Research Alliance Corporation III For: 27 July By Investing.com - Investing.com Nigeria
Research Alliance to Acquire OHB Pediatrics in Stock Deal Valued at $160 Million Plus SAFEs - TradingView
Oak Hill Bio, Research Alliance III (RACC) plan SPAC merger - Stock Titan
Oak Hill Bio and Research Alliance Corporation III Announce Business Combination Agreement to Create Publicly Listed Rare Disease Biotechnology Company to Advance Antisense Oligonucleotide Therapy Rugonersen for Angelman Syndrome - Yahoo Finance
Research Alliance Corporation IV Revenue Breakdown – NASDAQ:RACD - TradingView
PERCEPTIVE ADVISORS LLC Acquires 700,000 Shares in Research Alli - GuruFocus
Meridia RE IV Socimi announces EUR 0.01 per share dividend for 2025 results - Bitget
COMMODORE CAPITAL LP Acquires 500,000 Shares in Research Alliance Corp IV - GuruFocus
RACD Price History for Research Alliance Corporation IV Cl A Stock - Barchart.com
RACD: Research Alliance Corporation IVFull Company Report - Zacks Investment Research
Research Alliance Holdings IV LLC Discloses Investment in Research Alliance Corporation IV with 17% Stake - TradingView
Research Alliance Corporation IV (RACD) sponsor reports 17% ownership - Stock Titan
Research Alliance Corp IV (RACD) investor group reports 5.5% ownership of Class A shares - Stock Titan
Research Alliance Corporation IV (RACD) 10K Form and Latest SEC Filings 2026 - MarketBeat
Biotechnology Value Fund (RACD) group reveals 6.4% Research Alliance stake - Stock Titan
Research Alliance Corporation IV Completes Initial Public Offering - TipRanks
Research Alliance IV prices IPO for $75M, deposits $75M trust; sponsor buys $2.75M private placement - TradingView
Commodore Capital takes 5.5% position in Research Alliance Corp IV (RACD) - Stock Titan
RACD Stock Latest News - TipRanks
Perceptive Advisors reports 7.7% RACD stake in Research Alliance Corporation IV (RACD) - Stock Titan
Frontier tech research, news & data - MLQ.ai
RACD SEC FilingsResearch Alliance Corp IV 10-K, 10-Q, 8-K Forms - Stock Titan
RACD News Today | Why did Research Alliance Corporation IV stock go up today? - MarketBeat
Research Alliance Corporation IV (RACD) Stock Price, News & Analysis - MarketBeat
U.S. IPO Weekly Recap: Csquare And Standard Nuclear Both Underwhelm Amid Cautious Market - Seeking Alpha
Research Alliance Corporation IV (RACD) stock historical prices and data - Yahoo Finance Australia
Cash flow from operating activities of Research Alliance Corporation IV – NASDAQ:RACD - TradingView
Weekly news roundup: Legal trouble for Google, New York pauses data centers and Muse Image retreat - TechTarget
Research Alliance Corp IV (RACD) grants 275,000 shares to director entity - Stock Titan
Research Alliance Corp IV (RACD) sponsor gets 275K share grant - Stock Titan
Research Alliance Corporation IV (RACD) seeks $75M SPAC IPO - Stock Titan
Book value per share of Research Alliance Corporation IV – NASDAQ:RACD - TradingView
RACD Price Today: Research Alliance Corporation IV Stock Price, Quote & Chart - mexc.co
Price to sales forward of Research Alliance Corporation IV – NASDAQ:RACD - TradingView
Research Alliance Corporation IV (RACD) Stock Chart and Price History 2026 - MarketBeat
Research Alliance Corporation IV Prices $75 Million IPO, Targets Healthcare Sector on Nasdaq - Minichart
Research Alliance IV Completes $75 Million SPAC IPO, Inks Trust, Underwriting and $2.75 Million Private Deal - TradingView
Research Alliance Corporation IV (RACD) completes $75M IPO and trust funding - Stock Titan
Research Alliance Corp IV SEC Filing (Jul 13, 2026) - Stock Titan
Research Alliance Corp IV (NASDAQ: RACD) files exhibits-only registration update - Stock Titan
Research Alliance Corp Iv Stock (RACD) Financials Data
There is no financial data for Research Alliance Corp Iv (RACD). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):